Repligen Co News Today

Rhenman & Partners Asset Management AB acquired a new stake in Repligen Co. (NASDAQ:RGEN – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 10,000 shares of the biotechnology company’s stock, valued at approximately $1,798,000. A number of other hedge […]

BNP Paribas Asset Management Holding S.A. reduced its holdings in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 4.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 330,848 shares of the biotechnology company’s stock after selling 14,538 shares during the […]

BNP Paribas Asset Management Holding S.A. trimmed its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 4.2% during the fourth quarter, HoldingsChannel.com reports. The firm owned 330,848 shares of the biotechnology company’s stock after selling 14,538 shares during the quarter. BNP Paribas Asset Management Holding S.A.’s holdings in Repligen were worth $59,486,000 as of […]

Intrust Bank NA lowered its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 9.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,364 shares of the biotechnology company’s stock after selling 136 shares during the period. Intrust Bank NA’s holdings in […]

Repligen Co. (NASDAQ:RGEN – Get Free Report)’s stock price gapped up prior to trading on Tuesday . The stock had previously closed at $157.48, but opened at $166.49. Repligen shares last traded at $171.99, with a volume of 139,951 shares changing hands. Analyst Ratings Changes A number of research analysts have weighed in on RGEN […]

LRT Capital Management LLC raised its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 9.6% in the fourth quarter, HoldingsChannel.com reports. The fund owned 5,707 shares of the biotechnology company’s stock after purchasing an additional 502 shares during the quarter. LRT Capital Management LLC’s holdings in Repligen were worth $1,026,000 as of its most […]

LRT Capital Management LLC lifted its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 9.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,707 shares of the biotechnology company’s stock after purchasing an additional 502 shares during the quarter. LRT […]

Repligen Co. (NASDAQ:RGEN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the nine brokerages that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average 12-month price target […]

Dana Investment Advisors Inc. lowered its stake in Repligen Co. (NASDAQ:RGEN – Free Report) by 36.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,437 shares of the biotechnology company’s stock after selling 2,546 shares during the period. Dana Investment Advisors […]

Dana Investment Advisors Inc. lessened its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 36.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,437 shares of the biotechnology company’s stock after selling 2,546 shares during […]